Khattar Jack A. (CIK 0001539937)

Latest company ownership

Shares held
1,005,600
Last filed at
Oct 10, 2025
Confidence Score
29.0
2025Q4
Confidence Score History
2013Q1 2025Q4
Shares held
6,124
Last filed at
Oct 7, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 9, 2025 Oct 10, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 36.3 -59,900 -2.64% ✓ $3M
Oct 2, 2025 Oct 3, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -15,325 -0.45% ✗ $708.2K
Oct 2, 2025 Oct 3, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 51.3 -1,904 -0.09% ✓ $91.5K
Oct 1, 2025 Oct 2, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 40.0 -40,173 -1.82% ✓ $1.9M
Sep 30, 2025 Oct 1, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 46.3 -8,588 -0.40% ✓ $414.4K
Sep 29, 2025 Sep 30, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 46.3 -10,235 -0.47% ✓ $491.5K
Sep 23, 2025 Sep 24, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 40.0 -29,513 -1.36% ✓ $1.4M
Sep 22, 2025 Sep 23, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -16,587 -0.77% ✓ $779.9K
Sep 8, 2025 Sep 9, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -6,322 -0.57% ✓ $292.6K
Sep 5, 2025 Sep 8, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 36.3 -55,578 -2.56% ✓ $2.6M
Aug 27, 2025 Aug 29, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 40.0 -34,800 -1.08% ✓ $1.6M
Aug 25, 2025 Aug 27, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 57.5 -1,000 -0.05% ✓ $45K
Aug 22, 2025 Aug 26, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 51.3 -1,500 -0.07% ✓ $67.5K
Aug 6, 2025 Aug 8, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 31.3 -140,000 -3.26% ✓ $5.9M
Mar 10, 2025 Mar 11, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -16,805 -0.83% ✗ $538.8K
Mar 7, 2025 Mar 7, 2025 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -18,581 -0.92% ✗ $726.7K
Dec 27, 2024 Dec 30, 2024 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -25,233 -0.86% ✗ $898K
Nov 8, 2024 Nov 12, 2024 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 17.5 -125,000 -6.03% ✗ $4.5M
Nov 7, 2024 Nov 8, 2024 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 17.5 -125,000 -6.03% ✗ $4.6M
Sep 3, 2024 Sep 3, 2024 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -10,045 -0.51% ✗ $350.6K
Feb 28, 2024 Feb 29, 2024 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -16,788 -0.86% ✗ $469.1K
Dec 22, 2023 Dec 26, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -11,958 -0.62% ✗ $330.8K
Sep 7, 2023 Sep 7, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -16,804 -0.87% ✗ $539.4K
May 11, 2023 May 12, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -15,005 -0.79% ✗ $547.2K
Feb 2, 2023 Feb 6, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 46.3 -13,332 -0.50% ✓ $560.7K
Feb 1, 2023 Feb 3, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 57.5 -300 -0.02% ✓ $12.6K
Jan 31, 2023 Feb 2, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 55.0 -976 -0.05% ✓ $41K
Jan 18, 2023 Jan 20, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 48.8 -4,936 -0.27% ✓ $199.4K
Jan 17, 2023 Jan 19, 2023 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 40.0 -25,446 -1.36% ✓ $1M
Dec 20, 2022 Dec 22, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 55.0 +265 0.01% ✓ $585.4K
Nov 23, 2022 Nov 28, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -13,394 -0.51% ✓ $470.9K
Nov 22, 2022 Nov 23, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 57.5 -600 -0.03% ✓ $21K
Nov 21, 2022 Nov 22, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 57.5 -531 -0.03% ✓ $18.6K
Nov 15, 2022 Nov 17, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 55.0 -1,115 -0.06% ✓ $39K
Aug 16, 2022 Aug 18, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -14,690 -0.80% ✓ $499.7K
Aug 15, 2022 Aug 17, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 45.0 -17,302 -0.95% ✓ $588.8K
Aug 10, 2022 Aug 11, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 42.5 -28,437 -1.56% ✓ $887.8K
Aug 9, 2022 Aug 10, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 36.3 -39,431 -2.17% ✓ $1.2M
Aug 8, 2022 Aug 9, 2022 SUPERNUS PHARMACEUTICALS, INC. CEO Sell 27.5 -117,907 -6.30% ✓ $3.7M
Dec 3, 2021 Dec 6, 2021 scPharmaceuticals Inc. Director Buy 91.3 +5,000 100.00% ✗ $19.6K
Aug 23, 2019 Aug 27, 2019 SUPERNUS PHARMACEUTICALS, INC. CEO Buy 65.0 +7,200 0.47% ✗ $190K
Mar 15, 2013 Mar 19, 2013 SUPERNUS PHARMACEUTICALS, INC. CEO Buy 72.5 +10,000 0.65% ✓ $61.5K